.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for addition of clients with MASLD as well as measurement of liver outcomes in cardio-- kidney-- metabolic trials, when records recommend mechanistically plausible benefits and also medical security-- and outlines factors to consider for test design and also regulative commendation.